- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/475 - Facteurs de croissanceRégulateurs de croissance
Détention brevets de la classe C07K 14/475
Brevets de cette classe: 1677
Historique des publications depuis 10 ans
|
129
|
118
|
119
|
155
|
145
|
143
|
113
|
110
|
97
|
55
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Acceleron Pharma Inc. | 358 |
40 |
| The Board of Trustees of the Leland Stanford Junior University | 6424 |
25 |
| The General Hospital Corporation | 4735 |
25 |
| The Regents of the University of California | 19943 |
24 |
| Amgen Inc. | 4049 |
21 |
| Modernatx, Inc. | 1262 |
20 |
| Zensun (Shanghai) Science & Technology, Co., Ltd. | 55 |
20 |
| NGM Biopharmaceuticals, Inc. | 179 |
19 |
| The Brigham and Women's Hospital, Inc. | 2186 |
18 |
| Genentech, Inc. | 3983 |
16 |
| Regeneron Pharmaceuticals, Inc. | 4261 |
16 |
| Children's Medical Center Corporation | 1863 |
15 |
| President and Fellows of Harvard College | 5973 |
13 |
| Centre National de La Recherche Scientifique | 10442 |
12 |
| Scholar Rock, Inc. | 117 |
12 |
| The Johns Hopkins University | 5671 |
11 |
| Silver Creek Pharmaceuticals, Inc. | 29 |
11 |
| The Trustees of the University of Pennsylvania | 4329 |
10 |
| Northwestern University | 3400 |
10 |
| Eli Lilly and Company | 3848 |
10 |
| Autres propriétaires | 1329 |